FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

430868007: Rilonacept (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2759776016 Rilonacept (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2771708017 Rilonacept en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rilonacept (substance) Is a Fusion protein (substance) true Inferred relationship Some
Rilonacept (substance) Is a Recombinant interleukin 1 receptor antagonist true Inferred relationship Some
Rilonacept (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Recombinant interleukin 1 receptor antagonist (disposition) true Inferred relationship Some
Rilonacept (substance) Is a Immunologic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Rilonacept 220mg powder for injection solution 20ml vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rilonacept (substance) Inferred relationship Some
Product containing rilonacept (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rilonacept (substance) Inferred relationship Some 1
Rilonacept only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rilonacept (substance) Inferred relationship Some 1
Product containing precisely rilonacept 220 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Rilonacept (substance) Inferred relationship Some 1
Product containing precisely rilonacept 220 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Rilonacept (substance) Inferred relationship Some 1
Rilonacept-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rilonacept (substance) Inferred relationship Some 1
Rilonacept only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Rilonacept (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start